论文部分内容阅读
目的:评价宫瘤消胶囊与米非司酮联用治疗子宫肌瘤患者的临床疗效。方法:选取2013年6月—2015年6月间收治的子宫肌瘤患者102例,将其分为对照组和联用组,每组51例;对照组患者均给予米非司酮治疗,联用组患者均给予米非司酮与宫瘤消胶囊联用治疗,比较两组患者治疗后的总有效率、治疗前后子宫肌瘤体积和雌激素水平的变化情况。结果:联用组患者治疗后的总有效率为90.20%,高于对照组为74.51%(P<0.05)。结论:采用米非司酮与宫瘤消胶囊联用治疗子宫肌瘤患者的临床疗效优于单用米非司酮的疗效。
Objective: To evaluate the clinical efficacy of Mianyuoxiao capsule combined with mifepristone in the treatment of patients with uterine fibroids. Methods: A total of 102 patients with uterine fibroids who were admitted between June 2013 and June 2015 were selected and divided into control group and combined group, with 51 cases in each group. Patients in control group were treated with mifepristone, The patients in both groups were treated with mifepristone and Gongyu Xiaozhu Capsule. The total effective rate, the volume of uterine fibroids and estrogen levels before and after treatment were compared between the two groups. Results: The total effective rate after treatment in combination group was 90.20%, which was 74.51% higher than that in control group (P <0.05). Conclusion: The clinical efficacy of mifepristone combined with Gongyu Xiao capsule in the treatment of uterine fibroids is superior to that of mifepristone alone.